EVNIN LUKE

Average Profitability
16.52%
Insider Buys Quantity
7
Insider Buys Sum
$28.35M
Insider Sells Quantity
41
Insider Sells Sum
$92.66M

Insider Activity of EVNIN LUKE

The largest purchase of all time was on 2011-02-08 and amounted to 1071428 shares of Pacira BioSciences, Inc. for $7.5M.

The largest sale of all time was on 2013-03-18 and amounted to 1000000 shares of Pacira BioSciences, Inc. for $28.44M.

Biography of EVNIN LUKE

No biography is available at this moment.

2021-05-04PurchaseWerewolf Therapeutics, Inc.
HOWL
150,799
0.848%
$16.00$2.41M-12.48%
2020-12-23PurchaseWerewolf Therapeutics, Inc.
HOWL
15.88M
–
$0$0
2013-06-13SalePacira BioSciences, Inc.
PCRX
director
40,622
0.122%
$30.07$1.22M+80.52%
2013-06-12SalePacira BioSciences, Inc.
PCRX
director
4,870
0.0148%
$30.00$146,100+82.64%
2013-06-03SalePacira BioSciences, Inc.
PCRX
director
164,144
0.4968%
$30.00$4.92M+80.17%
2013-05-31SalePacira BioSciences, Inc.
PCRX
director
19,870
0.0615%
$30.00$596,100+83.28%
2013-05-30SalePacira BioSciences, Inc.
PCRX
director
89,164
0.2698%
$30.00$2.67M+78.98%
2013-05-29SalePacira BioSciences, Inc.
PCRX
director
40,822
0.1237%
$30.00$1.22M+79.08%
2013-05-28SalePacira BioSciences, Inc.
PCRX
director
390,234
1.2326%
$30.95$12.08M+80.82%
2013-05-22SalePacira BioSciences, Inc.
PCRX
director
14,680
0.0458%
$30.00$440,400+83.15%
2013-05-20SalePacira BioSciences, Inc.
PCRX
director
13,550
0.0432%
$30.00$406,500+85.64%
2013-04-24SalePacira BioSciences, Inc.
PCRX
director
12,606
0.0392%
$30.04$378,684+73.34%
2013-04-23SalePacira BioSciences, Inc.
PCRX
director
216,230
0.6562%
$30.00$6.49M+69.13%
2013-04-15SalePacira BioSciences, Inc.
PCRX
director
5,150
0.0162%
$30.00$154,500+71.25%
2013-04-12SalePacira BioSciences, Inc.
PCRX
director
23,416
0.0706%
$29.90$700,089+64.96%
2013-03-18SalePacira BioSciences, Inc.
PCRX
director
1M
3.0745%
$28.44$28.44M+44.02%
2013-03-11SalePacira BioSciences, Inc.
PCRX
director
500,000
1.4545%
$27.86$13.93M+28.59%
2012-02-08PurchasePacira BioSciences, Inc.
PCRX
1.07M
2.8185%
$7.00$7.5M+49.38%
2011-11-21PurchasePacira BioSciences, Inc.
PCRX
923,076
4.9798%
$6.50$6M+54.02%
2011-02-08PurchasePacira BioSciences, Inc.
PCRX
1.07M
11.1451%
$7.00$7.5M+33.11%
Company
About Prismo.proNewsPrivacy PolicyTerms of ServiceContact Us
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.